Subcutaneous ICD Ekes Out Favorable Safety Signals 8 Years Into PRAETORIAN Trial

(MedPage Today) -- Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped their case.
Altogether, the...